News

Oral Therapy Evrysdi Approved for Spinal Muscular Atrophy

By

Brian Park, PharmD

Publish Date August 12, 2020

Evrysdi is a survival motor neuron-2 (SMN2) splicing modifier.

The Lancet Commission Identifies Additional Dementia Risk Factors

By

Heather Johnson

Publish Date August 12, 2020

The Lancet Commission added 3 new risk factors for dementia that coupled with the previous 9 lifestyle risk factors might prevent or delay up to 40% of dementias worldwide.

COVID-19 Tied to Higher Risk for Large Vessel Occlusion Strokes

Publish Date August 12, 2020

COVID-19 is associated with large vessel occlusion strokes.

SARS-CoV-2 Antibodies Detected in 13.7% of NYC HCPs

Publish Date August 12, 2020

Among health care providers in the New York City area, 13.7% have SARS-CoV-2 antibodies, a rate similar to adults randomly tested in New York state.

Sleep Fragmentation Associated with Cognitive Impairment in ICU Survivors

By

Amit Akirov, MD

Publish Date August 11, 2020

Early sleep fragmentation, estimated by actigraphy, was found to be associated with worse cognitive impairment shortly after critical illness.

Mood Disorders Affect Ability to Adapt to Changes Due to COVID-19

By

Jessica Nye, PhD

Publish Date August 11, 2020

Investigators conducted a population-based study in which a survey was deployed to assess the impact of the COVID-19 pandemic on mental health and well-being.

Atogepant Reduces Monthly Migraine Days in Phase 3 Prevention Trial

By

Brian Park, PharmD

Publish Date August 11, 2020

The ADVANCE study included 910 adults who experienced 4 to 14 migraines per month.

Relapse Rates Lower With Ofatumumab in Multiple Sclerosis

Publish Date August 11, 2020

Annualized relapse rates are lower for patients with relapsing MS receiving anti-CD20 monoclonal antibody ofatumumab compared with teriflunomide.

Spravato Approved for MDD With Acute Suicidal Ideation or Behavior

By

Brian Park, PharmD

Publish Date August 10, 2020

The approval was based on the ASPIRE I and II trials that compared the efficacy and safety of esketamine, an N-methyl-D-aspartate receptor antagonist, to placebo in 449 adults with moderate to severe MDD who had active suicidal ideation and intent.

Botox Injections May Ease Depression

Publish Date August 10, 2020

Botox injections, which are commonly used to lessen wrinkles, migraines, muscle spasms, excessive sweating, and incontinence, may also help treat depression.